WebDec 16, 2012 · The situation looks bleak for BioChemics. For starters, as summarized in the SEC complaint, each of the individual defendants has had a prior serious run-in with a securities regulator. In 2004, for example, the SEC charged Masiz with fraudulent statements in the securities filings of VASO Active Pharmaceuticals, Inc., a BioChemics … WebBiochemics, Inc. has not filed any forms with the United States Securities and Exchange Commission. Date Recorded: Party: Role: Document Type: Document No. Invention Title: 4/14/2024: Convergent Distributors Of Texas LLC: Assignee: Application Application Application Application Application Application Application Application
BioChemics Inc - Company Profile and News - Bloomberg …
WebInnovative Separation Highlights News 1 min Nucleic Acid Purification NA-Filter is built based on a revolutionary technology of filtration with special membrane. Hollow-Fiber … WebBut the largest companies in Silicon Valley are trying to change that, using virtual sports platforms to drive adoption and profit in this new world. Bloomberg Radio Meet the Press … merakey act lake charles
Biopharmaceutical Companies in India- Biogenomics
WebLaw360 (December 10, 2024, 6:32 PM EST) -- A receiver appointed to help liquidate the assets of BioChemics Inc. as the government tries to collect on a nearly $18 million securities fraud... WebBioChemics is a pharmaceutical company that has developed a portfolio of novel topical and transdermal drug delivery systems that allow a substantial amount of drugs that … WebFeb 15, 2013 · The primary objective of this study is to assess the magnitude and duration of pain relief resulting from a fixed dose of BC-DN-01, compared to placebo, in patients with painful DPN as measured by the Brief Pain Inventory (BPI). Secondary Outcome Measures : Safety of BC-DN-01 [ Time Frame: 120 days ] merakey 800 chester pike sharon hill pa